Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Invested Capital (2016 - 2025)

Utah Medical Products has reported Return on Invested Capital over the past 15 years, most recently at 0.0% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.0% for Q4 2025, down 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (down 9.0% YoY), and the annual figure for FY2025 was 0.0%, down 2.0%.
  • Return on Invested Capital for Q4 2025 was 0.0% at Utah Medical Products, down from 0.07% in the prior quarter.
  • Over the last five years, Return on Invested Capital for UTMD hit a ceiling of 0.13% in Q3 2022 and a floor of 0.0% in Q4 2025.
  • Median Return on Invested Capital over the past 5 years was 0.08% (2025), compared with a mean of 0.07%.
  • Biggest five-year swings in Return on Invested Capital: rose 12bps in 2022 and later decreased -11bps in 2023.
  • Utah Medical Products' Return on Invested Capital stood at 0.12% in 2021, then rose by 2bps to 0.12% in 2022, then crashed by -91bps to 0.01% in 2023, then soared by 768bps to 0.09% in 2024, then plummeted by -105bps to 0.0% in 2025.
  • The last three reported values for Return on Invested Capital were 0.0% (Q4 2025), 0.07% (Q3 2025), and 0.08% (Q2 2025) per Business Quant data.